Renal + Urology News highlighted research led by the University of Cincinnati's Alberto Martini, MD, that found using ...

Patients receiving an immune checkpoint inhibitor for a neoplasm face an increased risk for rheumatoid arthritis, an ...

What factors influence the success or failure of immunotherapy treatment in patients with advanced bladder cancer? Why do ...

Scientists have discovered a novel subset of cancer-fighting immune cells that reside outside of their normal neighborhood -- known as the tertiary lymphoid structure -- where they become ...

John Ryan, a U.S. Navy veteran, beat cancer through nearly a decade of experimental immunotherapy treatment. The vet shared ...

Immunotherapy is leading the charge in the advancement of cancer treatment. In addition to increased life expectancy, it ...

Mayo Clinic researchers say because ovarian cancer has limited symptoms, it can go undetected until it has spread. At a later ...

Racial and ethnic disparities were identified in immunotherapy receipt for Black patients with metastatic triple-negative ...

Photoimmunotherapy is an innovative cancer treatment that combines phototherapy with immunotherapy to selectively target and ...

The Penn physician-researcher has received more funding to advance his 'Trojan horse' for attacking gastroesophageal cancer.

Patients with localized muscle-invasive bladder cancer (MIBC) who received radiation plus the immune checkpoint inhibitors (ICIs) durvalumab (Imfinzi) and tremelimumab (Imjudo) had durable responses ...

A combination immunotherapy may help cure a majority of patients with melanoma -- a deadly skin cancer -- that has spread to ...